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The hemodynamic determinants of the 
isovolumic index 
The isovolumic index is a recently described echocardiographic parameter of left ventricular 
function that is calculated as the ratio between the sum of the time of isovolumic contraction and 
relaxation divided by the ejection time. Although the individual components of this index may be 
altered by heart rate and loading conditions, an analysis of the net effect of such alterations on 
the isovolumic index has not been undertaken. Thus, dogs were instrumented with hlgh-fidelity 
micromanometers in the left ventricle, ascending aorta, and left atrium to allow determination of 
the individual components of the isovolumic index and calculation of the index itself. Four sets of 
experiments were undertaken in random order. Left atrial pacing was used to increase heart rate 
by approximately 10 bpm in five steps. Preload was elevated in five stages by saline infusions 
which caused successive increases of 1 to 2 mm Hg in the left ventricular end-diastolic pressure. 
Systolic blood pressure was lowered or raised by approximately 10 mm Hg per stage by three 
progressive, steady-state infusions of nitroprusside and phenylephrine, respectively. These 
experiments demonstrated little change in the isovolumic index over a broad range of heart rate. 
Increased left ventricular end-diastolic pressure and decreased systemic pressure caused 
shortening of the index. Multiple regression analysis of all experiments yielded the following: 
isovolumic index = 0.41 - 0.015 (left ventricular end-diastolic pressure) + 0.004 (systolic blood 
pressure); r = 0.57, standard error = 0.13, p < 0.0001. Therefore, this investigation establishes 
the hemodynamic determinants of the isovolumic index and provides the basis for Interpretation 
of directional changes in response to cardiac diseases and cardioactive drugs that can alter 
loading conditions. (AM HEART J 1986;112:791.) 
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setting of left ventricular failure, the preejection 
period lengthens while the ejection time dimin- 
ishes.2-4 Second, it has become increasingly apparent 
that parameters of isovolumic relaxation are also 
abnormal under these circumstances.5-14 Thus, it was 
postulated that an “isovolumic index,” as defined 
above, might be abnormal in appropriate patient 
subgroups and might be more sensitive in detecting 
these patients noninvasively than the traditional 
systolic time index (ratio of preejection time to 
ejection time) which ignores abnormalities of isovo- 
lumic relaxation. 
Initial patient studies,’ demonstrated that the 
isovolumic index was abnormal in those with conges- 
tive cardiomyopathy and also in a substantial pro- 
portion with stable coronary artery disease. Despite 
these encouraging results, it was recognized that 
components of the index may be affected by heart 
rate and loading conditions.‘s8, 15-18 These possible 
effects require study before the potential clinical 
significance of directional changes in the isovolumic 
index secondary to ischemialg or cardioactive drugs 
can be determined. Thus, the purpose of this inves- 
tigation was to assess potential changes in the 
isovolumic index secondary to alterations of heart 
rate, preload, and afterload. 
METHODS 
Seventeen mongrel dogs of either sex (25.2 * 4.2 kg) 
were anesthetized with 35 mg/kg of sodium pentobarbital, 
intubated, and ventilated with a Harvard respirator. A left 
thoracotomy and left carotid arteriotomy were performed. 
The heart was supported in a preicardial cradle and 
high-fidelity micromanometers (No. 5F, Millar Instru- 
ments, Jnc, Houston Texas) were inserted via a left carotid 
arteriotomy into the ascending aorta, via a left ventricular 
apical stab wound into the left ventricle, and via a left 
atriotomy into the left atrium and then through the mitral 
valve into the left ventricle. The catheters were made 
equisensitive by matching the systolic blood pressure 
readings of the left ventricular and the aortic manometers 
and by matching the high-gain left ventricular diastolic 
pressures of the left atria1 and left ventricular catheters. 
Once achieved, the left atria1 catheter was withdrawn 
through the mitral valve into the left atrium. Frequent 
checks for zero drift were made throughout the experi- 
ments. Left atria1 pacing wires were sutured in place and 
were attached to an AV-120 Bloom stimulator (Bloom and 
Associates, Reading, Pa.). A pair of subendocardial ultra- 
sonic crystals were placed in the distribution of the left 
anterior descending coronary artery in the mid-equatorial 
plane of the ventricle. These were attached to a sonomi- 
crometer 120 (Triton Technology, San Diego, Calif.), 
which was interfaced to a Tektronix 2213A oscilloscope 
(Tektronix, Inc., Beaverton, Or.). Proper crystal align- 
ment was confirmed by oscilloscopic display of the crystal 
signals and by direct inspection at the conclusion of the 
experiment. All signals were recorded on an eight-channel 
Gould 2800s recorder (Gould Recording Systems, Cleve- 
land, Ohio), and reported values are averages from four to 
six beats recorded at 200 mm/set paper speed during 
steady states. 
Continuous recordings of left ventricular pressure, rate 
of change of pressure (dP/dt), aortic and atria1 pressure, 
segment lengths, and ECG ‘were made (Fig. 1). Left 
ventricular end-diastolic pressures were measured at the 
time when dP/dt became positive, and this was considered 
the onset of isovolumic contraction. End systole was taken 
at peak negative dP/dt, and this was considered the 
beginning of isovolumic relaxation.2U 
The isovolumic contraction time was determined as the 
time from end-diastolic pressure to peak positive dP/dt”’ 
(Fig. 2). The ejection time was determined as the time 
from peak positive to peak negative dP/dt.20.” The isovo- 
lumic relaxation time was taken from peak negative dP/dt 
to the point where left atria1 and left ventricular diastolic 
pressures crossed over.22’Z6 The isovolumic index was 
defined as (IVC + IVR)/ET, where IVC = isovolumic con- 
traction time, IVR = isovolumic relaxation time, and 
ET = left ventricular ejection time. The systolic time 
index was defined as IVC/ET. Segment shortening was 
defined as segment excursion between end diastole and 
end systole divided by end-diastolic length and multiplied 
by 100. To determine directional changes in relaxation, an 
estimate of the isovolumic relaxation time constant was 
determined by dividing the left ventricular pressure at 
peak negative dP/dt by peak negative dP/dt.” ‘(‘I 
The experimental protocol was randomized into four 
phases with ample time between each to reattain steady- 
state hemodynamics. The effects of changing heart rate 
was assessed by incremental atria1 pacing in steps of 
approximately 10 bpm at five successive levels. The effects 
of volume loading were assessed by infusing saline in 50 to 
150 cc amounts to obtain five increasing levels of left 
ventricular end-diastolic pressure. Afterload was altered 
by three incremental infusions of nitroprusside and phen- 
ylephrine in order to cause steady-state reductions and 
elevations, respectively, of systolic pressure of approxi- 
mately 10 to 15 mm Hg per stage. 
All results were analyzed by repeated measures analysis 
of variance. When overall significance was detected, a 
Bonferonni test was utilized to determine which stages 
were significantly different from controL3’ A p value of 
less than 0.05 was considered significant. Results are 
reported as mean rt standard deviation. Data from all 
four phases were combined for a stepwise regression 
procedure to determine which combination of parameters 
best explained the variations in the isovolumic index. 
When hemodynamic instability, arrhythmias, non-steady- 
state conditions, crystal misalignment, or excessive zero- 
drift of pressure measurements were found, the data from 
all stages of that experiment were excluded from analysis. 
Full complements of data at each desired level were 
obtained in 12 dogs for the atria1 pacing protocol, in eight 
dogs during saline loading, in 13 dogs during nitroprusside 
infusion, and in 11 dogs during phenylephrine infusion. 
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Fig. 1. Recordings at 2 mm/set and at 50 mm/set paper speed showing pressure, segment length, and 
electrocardiographic data. The fifth channel shows pressures as the left atria1 manometer is pulled into 






Fig. 2. Markers used for calculating time intervals are shown. AB = isovolumic contraction time; 
EC = ejection time; CD = isovolumic relaxation time; AE = full cycle length. Point D is determined from 
the crossover of left ventricular diastolic pressure and left atria1 pressure. dP/dt is the rate of change of left. 
ventricular pressure with time. 
RESULTS 
Atrial pacing (n = 12). Table I summarizes the 
results of the atrial pacing protocol. Stepwise incre- 
ments in heart rate occurred from control values of 
129 -t 17 to 177 + 17 bpm. Left ventricular end- 
diastolic pressure and systolic blood pressure did 
not change. Peak negative dP/dt and the isovolumic 
relaxation time constant also showed no significant 
changes. A rate-dependent increase in peak positive 
dP/dt and deterioration in segment shortening were 
noted at the highest levels of pacing. All time 
intervals progressively shortened with increasing 
heart rate, and this was greatest for the ejection time 
and least for the isovolumic contraction time. This 
resulted in a small but significant increase in the 
systolic time index (IVCYET). Although a downward 
trend in the isovolumic index was noted, these 
changes were not significant. Excluding the last two 
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Table 1. Effects of incremental atria1 pacing on hemodynamics and time intervals 
Incremental atrial pacing levels 
Control 1 2 3 4 
Heart rate (bpm) 
Left ventricular end-diastolic 
pressure (mm Hg) 
Systolic blood pressure (mm 
Hs) 
Peak positive dP/dt (mm 
Hg/sec) 
Peak negative dP/dt (mm 
Hg/sec) 
T (msec) 
Segment shortening ( ci ) 
Ejection time (msec) 
Isovolumic contraction time 
(msec) 
Isovolumic relaxation time 
(msec) 
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Values are mean r S.D. 
dP/dt = rate of pressure change with respect to time, T is the isovolumic relaxation time constant. 
*p < 0.05 “S control. 
tp < 0.01 “S control. 
$p < 0.001 “S control. 
rates of extreme tachycardia when fractional short- 
ening was mildly impaired, the isovolumic index 
showed no significant change over a heart rate range 
of approximately 30 bpm, whereas the systolic time 
index showed a very mild prolongation. 
Saline loading (n = 8). Left ventricular end-diastol- 
ic pressure changed significantly in a stepwise fash- 
ion from 8 +_ 2 to 16 +_ 2 mm Hg (Table II). Heart 
rate showed no significant change, whereas systolic 
blood pressure rose significantly with the highest 
infusions. The elevation during stage four, however, 
did not reach statistical significance. Peak positive 
dP/dt was elevated relative to control during the last 
three infusions. Peak negative dP/dt remained con- 
stant, whereas the isovolumic relaxation time con- 
stant increased from 40 + 13 msec to 45 +- 11 and 
46 +- 12 msec during the fourth and fifth stages, 
respectively. Segment shortening showed the 
expected improvement with volume loading. The 
ejection time showed progressive prolongation in the 
face of progressive shortening of the isovolumic 
contraction time and a constant isovolumic relax- 
ation time. This caused a significant decrease in 
both the systolic time index and the isovolumic 
index (Fig. 3). These changes were significantly 
different from control, even during the first stage of 
infusion when all other parameters except end- 
diastolic pressure remained unchanged. 
Nitroprusside infusion (n = 13). Table III demon- 
strates the progressive fall in systolic blood pressure 
achieved with nitroprusside infusion. This was asso- 
ciated with a 10 to 12 bpm increase in heart rate and 
a 2 to 3 mm Hg fall in left ventricular end-diastolic 
pressure. Both peak positive and negative dP/dt fell 
during this experiment, whereas segment shortening 
remained constant and the isovolumic relaxation 
time constant shortened. Significant abbreviation of 
both isovolumic contraction and relaxation times in 
conjunction with a constant ejection time resulted in 
a significant decrease in both the isovolumic index 
and the systolic time index (Fig. 4). It should be 
noted that changes of heart rate in this experiment 
cannot account for the changes in the isovolumic 
index or the systolic time index (see Table 1). 
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Table II. The effects of volume loading on hemodynamics and time intervals 
--__-~ 
.S’a/~n~ infusions 
_.~ _ ~-.-~-.-- -. ~~~~~--- ~~~. 
Control 1 2 :j 
Left ventricular end-diastolic 
pressure (mm Hg) 
Heart rate (bpm) 
Systolic blood pressure (mm 
I-k) 
Peak positive dP/dt (mm 
Hg/sec) 
Peak negative dP/dt (mm 
H&X) 
T (mset:) 
Segment shortening (‘c,) 
Ejection time (msec) 
Isovolumic contraction time 
(msec) 
Isovolumic relaxation time 
( msec) 









*374 + 369 
2014 1931 




18.7 zk 8.9 
184 1971 




































Values are mean + SD. 
dP/dt = rate of’ pressure change with respect to time, T  is the isovolumic relaxation time constant,. 
*p < 0.05 “h control. 
tp < 0.01 VP control. 
$p < 0.001 X~S rmtrol 
Similarly, the decrease in left ventricular end- 
diastolic pressure would not be expected to cause a 
fall in these indices (see Table II). 
Phenylephrine infusion (n = 11). Systolic blood 
pressure rose significantly by approximately 15 mm 
Hg in each stage (Table IV, Fig. 4). A slight but 
significant fall in heart rate of approximately 7 bpm 
occurred in the final stage, and the left ventricular 
end-diastolic pressure rose during the final two 
stages of the protocol. Peak positive and negative 
dP/dt showed small increases. Fractional shortening 
remained constant and the isovolumic relaxation 
time constant showed the anticipated prolongation, 
which was paralleled by a significant lengthening of 
the isovolumic relaxation time. Isovolumic contrac- 
tion time remained constant and the ejection time 
showed mildly progressive prolongation that was not 
significant until stage three. Compared to saline 
loading, the increase in left ventricular end-diastolic 
pressure with phenylephrine infusion was not mani- 
fested in a progressive shortening of either the 
isovolumic index or the systolic time index in the 
face of rising systemic pressure. Both indices 
remained constant. 
Regression analysis. Stepwise regression analysis 
on all data yielded: IV1 = 0.41 - 0.015 LVEDP 
+ 0.004 SBP, r = 0.57, standard error = 0.13; where 
IV1 is the isovolumic index, LVEDP is the left- 
ventricular end-diastolic pressure, and SBP is the 
systolic blood pressure. All factors were highly sig- 
nificant at p < 0.0001. Heart rate effects were not 
significant in this analysis. In contrast, regression of 
the systolic time index (STI) showed: ST1 = 
0.12 + 0.009 HR - 0.007 LVEDP + 0.001 SBP, 
r = 0.63, SEE = 0.05; where HR is heart rate. Thus, 
the ST1 was slightly more correlated overall with the 
hemodynamic and heart rate effects. 
DISCUSSION 
The isovolumic index is determined by a complex 
interplay between three distinct phases of the cardi- 
ac cycle: ejection time, isovolumic contraction time, 
and isovolumic relaxation time. Therefore, the con- 
clusions of this investigation depend on the validity 
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LEFT VENTRICULAR 
END-DIASTOLIC 
PRESSURE (mm Hg) 
Fig. 3. The effects of saline loading on the left ventricu- 
lar end-diastolic pressure and the isovolumic index. 
of the observed directional changes of these inter- 
vals. The ejection time has previously been shown to 
vary inversely with heart rate,2* l5 and to increase 
with enhanced left ventricular filling,2,32 and 
enhanced systemic afterload. Decreased afterload 
prolongs the left ventricular ejection time if stroke 
volume is augmented. 34 This study confirmed these 
findings, except that the ejection time remained 
constant during nitroprusside infusion. This may 
have resulted from a lack of increase in stroke 
volume because of concomitant lowering of filling 
pressures. This is corroborated by the failure of 
myocardial shortening to increase (Table IV). 
The isovolumic contraction time revealed only a 
slight fall with increasing heart rate changes and a 
decrease during both saline loading and nitroprus- 
side infusion. Again, these findings are in keeping 
with prior observations. 15, l6 During phenylephrine 
infusion, however, this interval did not change, in 
contrast to the work of Harris et a1.35 and Shaver et 
al 33 that demonstrated prolongation with pressor 
agents. In the current study, preservation of myocar- 
dial shortening by maintenance and enhancement of 
left ventricular filling may have prevented changes 
in the stroke volume and, hence, isovolumic con- 
traction time is expected to remain constant (Ta- 
ble III) .36 
The third important interval is the isovolumic 
relaxation time. This interval has been shown to be 
affected by the level of aortic closing pressure, the 
left atria1 pressure, and the rate of left ventricular 
pressure fa11.14s 17,37 In this study, no significant alter- 
ation in isovolumic relaxation time was noted during 
saline infusion despite significant elevations of left 




SYSTOLIC BLOOD PRESSURE 
(mm Hg) 
Fig. 4. The change in the isovolumic index (WI) is 
shown as a function of the change in systolic blood 
pressure. Squares represent mean observations during 
nitroprusside infusions and diamonds represent those 
during phenylephrine infusion. 
pressures. This can be explained by the offsetting 
effects of elevated systolic pressure and the prolong- 
ed rate of isovolumic relaxation.‘4~17~37-39 This was 
apparent during the phenylephrine infusions, when 
more marked elevations in systolic pressure were 
associated with prolongation of the isovolumic relax- 
ation time constant and the isovolumic relaxation 
time despite an increase in left ventricular end- 
diastolic pressures. Moreover, the opposite effects 
were noted during nitroprusside infusion, i.e., isovo- 
lumic relaxation time shortened in parallel with a 
shorter isovolumic relaxation time constant and 
decreasing systemic pressures. These latter effects 
offset the mild fall of left ventricular end-diastolic 
pressure that might have prolonged the isovolumic 
relaxation period. The effect of heart rate on the 
isovolumic relaxation time interval is less clearly 
defined, and investigators have reported no 
,-hange,‘8, 37,405 41 increases,14 or decreases.13 This inter- 
val is partially determined by the rate of fall of left 
ventricular pressure and the isovolumic relaxation 
time constant, both of which have been shown to be 
more rapid with increasing heart rate.38,42 In the 
current investigation, the isovo!umic relaxation time 
was not significantly differe.nt with changes in rate 
of approximately 20 bpm, but ‘at higher rates a 
progressive decrease appeared. These findings can- 
not be explained by changes in systemic pressures or 
filling pressures, because these remained constant. 
In addition, peak negative dP/dt and the isovolumic 
relaxation time constant were not significantly 
changed, although the latter tended toward progres- 
sive shortening. The use of the pressure crossover 
point of left ventricular and left atrial pressures may 
have been less closely related to mitral valve opening 
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Table 111. The effects of progressive hypotension induced by nitroprusside on hemodynamics and time intervals 
_ _~.____ -----.-~.~ - 
lncrcmentnl nitropruss~d~~ ~njw-i~v:.< 
Control I L’ :i 
___-__. _. .._^_--- 
Systolic hlood pressure (mm Hg) 133 1131 976 
222 + 2’L +“I _.. 
Heart rate (bpm) 143 147 153’ 
2 19 + IT’) _d + “6 
Left ventricular end-diastolic pressure (mm Hg) 7 5f 51 
*3 .k 2 t 1 
Peak positive dP/dt (mm Hgisec) 2‘171 219’2 2061 
t 604 i’iO4 t 852 
Peak negative dP/dt (mm Hgisec) 2253 1947 $ 1625$ 
s_616 1’ 694 i 697 
T (msecj 39.8 ?l6.5 :X3.;: 
It 10.2 f 9.0 t 8.9 
Segment shortening ( “cm ) 22.5 24.7 ‘3.2 
27.3 :t7.9 -8.1 
Ejection time (msec) 182 17:i 173 
t_23 i21 -- “5 
Isovolumic contraction time (msec) 61 5fif ;iZf 
+5 t: tj : 6 
Isovolumic relaxation time (msec) 94 i+* 74$ 
i16 i 14 2 1 1 
Systolic time index 0.34 I).33 0.30-F 
+_ 0.05 t 0.06 i i).Of< 
Isovolumic index 0.86 1j.82 0.7‘li 
20.12 i_Ci.l3 5 0.13 
__-_____~ 
Values are mean r SD. 
dP/dt = Iate of’ t>ressure change with respect to time, T  is the isovolumic relaxation tune constant, 
*p < 0.05 vs wntrcd. 
+&I < 0.01 “S <wmYr1. 
tp < O.Ol)l vs conlrd 
during rapid left atria1 pacing than at lower rates.2” 
Left atria1 pacing caused a very rapid and marked 
pressure rise in the left atrium. It is conceivable that 
the rapid pressure rise in the left atrium caused a 
progressive underestimation of actual mitral valve 
opening and the end of the isovolumic relaxation 
period. Thus, the effects of very large increases in 
heart rate in this study must be considered tenta- 
tive, whereas observations made within rate changes 
of approximately 20 bpm above control are in keep- 
ing with no significant alteration of either the 
isovolumic relaxation time or the isovolumic index. 
The results of multiple regression analysis confirm 
that heart rate changes do not affect the isovolumic 
index. 
Limited observations in dogs reported in the 
initial descriptive study of the isovolumic index 
showed an inverse relation between fractional short- 
ening and the isovolumic index.’ Fractional shorten- 
ing was altered by increasing left ventricular end- 
diastolic pressures in that study. The results shown 
in Table II confirm those results and also confirm 
the speculated preload dependence of the isovolum- 
ic index. Moreover, this dependence can be 
explained by prolongation of the ejection time and 
shortening of the isovolumic contraction time by 
saline loading. Although no overall correlation 
between the isovolumic index and ejection fraction 
was noted in patients, it is not yet clear whether 
directional changes in the isovolumic index will 
show a relationship to changes in shortening in the 
absence of loading changes; this will require further 
elucidation. Determination of the isovolumic index 
in patients at rest failed to reveal any relationship 
between this index and heart rate or systemic blood 
pressure.’ The current findings confirm the lack of 
major heart rate effects on the isovolumic index. In 
contrast, systemic pressure changes did influence 
the measurement of the isovolumic index, particu- 
larly with nitroprusside infusion. This drug brought 
about a shortening of both isovolumic periods and 
maintenance of a stable ejection time. Thus, the 
isovolumic index shortened. 
Although the isovolumic index is less correlated 
overall with hemodynamic and heart rate changes, a 
comparison of the directional changes in the isovo- 
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Table IV. The effects of progressive infusions of phenylephrine on hemodynamics and time intervals 
Incremental 
phenylephrine infusions 
Control 1 2 3 
Systolic blood pressure (mm Hg) 130 144t 
+ 15 + 13 
Heart rate (bpm) 147 146 
* 15 -t14 
Left ventricular end-diastolic pressure (mm Hg) 7 8 
22 +3 
Peak positive dP/dt (mm Hg/sec) 2082 2178 
k 467 + 425 
Peak negative dP/dt (mm Hg/sec) 2168 2283 
*518 + 520 
T (msec) 41.2 45.1 
k 12.6 +- 14.2 
Segment shortening (% ) 22.9 22.5 
-t 5.7 + 6.4 
Ejection time (msec) 184 187 
223 +24 
Isovolumic contraction 62 63 
*8 -+7 
Isovolumic relaxation time (msec) 87 93 
+ 17 *20 
Systolic time index 0.34 0.34 
+- 0.04 +0.04 
Isovolumic index (msec) 0.82 0.84 
+0.12 20.14 
values are mean + S.D. 
dp/dt = rate of pressure change with respect to time; T is the isovdumic r&m&n time constant. 
*p < 0.05 "S control. 
tp < 0.01 “S control. 








+- 309 k 292 
2343* 2313 
I! 549 + 547 
50.4* 57.1$ 
* 22.9 + 24.0 
23.4 21.4 
k 7.9 +- 10.3 
191 196t 






+ 0.04 + 0.03 
0.85 0.85 
kO.15 kO.15 
lumic index and the systolic time index (isovolumic 
contraction divided by the ejection time) shows that 
both indexes respond in a very similar fashion to 
load changes. However, it is clear that the ultimate 
advantage of the isovolumic index might be in those 
situations demonstrating selective abnormalities of 
isovolumic relaxation or when subtle abnormalities 
of both isovolumic contraction and relaxation are 
present. Indeed, the isovolumic index has been 
found to be abnormal in a small group of coronary 
patients with normal ratios of preejection time to 
ejection time,’ underscoring a potential superiority 
of the isovolumic index despite similar load depen- 
dency. 
In conclusion, this study establishes the hemody- 
namic determinants of the isovolumic index. It has 
been shown that the index is a load-dependent 
parameter that is independent of heart rate changes. 
The index shows a fall with decreasing systemic 
pressure and with physiologic increases in left ven- 
tricular end-diastolic pressure. Minimal change was 
noted in response to rising systemic pressure. A 
potential deterioration (prolongation), however, 
may have been offset by the progressively increased 
left ventricular end-diastolic pressure during phen- 
ylephrine infusion. As with other load-dependent 
parameters such as the ejection fraction or isovo- 
lumic parameters, detailed knowledge of the hemo- 
dynamic determinants of the isovolumic index are 
required before the significance of its directional 
changes in response to cardioactive drugs or ische- 
mia can be determined. Thus, this investigation 
provides the framework for future applications of 
the isovolumic index in the clinical setting. 
The authors wish to acknowledge the secretarial assistance of 
Diane Bauer and Marjorie LeRoy. 
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